Cargando…

HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)

We have discovered the sirtuin‐rearranging ligands (SirReals) as a novel class of highly potent and selective inhibitors of the NAD(+)‐dependent lysine deacetylase sirtuin 2 (Sirt2). In previous studies, conjugation of a SirReal with a ligand for the E3 ubiquitin ligase cereblon to form a so‐called...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiedel, Matthias, Lehotzky, Attila, Szunyogh, Sandor, Oláh, Judit, Hammelmann, Sören, Wössner, Nathalie, Robaa, Dina, Einsle, Oliver, Sippl, Wolfgang, Ovádi, Judit, Jung, Manfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754454/
https://www.ncbi.nlm.nih.gov/pubmed/32672888
http://dx.doi.org/10.1002/cbic.202000351
_version_ 1783626199017193472
author Schiedel, Matthias
Lehotzky, Attila
Szunyogh, Sandor
Oláh, Judit
Hammelmann, Sören
Wössner, Nathalie
Robaa, Dina
Einsle, Oliver
Sippl, Wolfgang
Ovádi, Judit
Jung, Manfred
author_facet Schiedel, Matthias
Lehotzky, Attila
Szunyogh, Sandor
Oláh, Judit
Hammelmann, Sören
Wössner, Nathalie
Robaa, Dina
Einsle, Oliver
Sippl, Wolfgang
Ovádi, Judit
Jung, Manfred
author_sort Schiedel, Matthias
collection PubMed
description We have discovered the sirtuin‐rearranging ligands (SirReals) as a novel class of highly potent and selective inhibitors of the NAD(+)‐dependent lysine deacetylase sirtuin 2 (Sirt2). In previous studies, conjugation of a SirReal with a ligand for the E3 ubiquitin ligase cereblon to form a so‐called proteolysis‐targeting chimera (PROTAC) enabled small‐molecule‐induced degradation of Sirt2. Herein, we report the structure‐based development of a chloroalkylated SirReal that induces the degradation of Sirt2 mediated by Halo‐tagged E3 ubiquitin ligases. Using this orthogonal approach for Sirt2 degradation, we show that other E3 ligases than cereblon, such as the E3 ubiquitin ligase parkin, can also be harnessed for small‐molecule‐induced Sirt2 degradation, thereby emphasizing the great potential of parkin to be used as an E3 ligase for new PROTACs approaches. Thus, our study provides new insights into targeted protein degradation in general and Sirt2 degradation in particular.
format Online
Article
Text
id pubmed-7754454
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77544542020-12-28 HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2) Schiedel, Matthias Lehotzky, Attila Szunyogh, Sandor Oláh, Judit Hammelmann, Sören Wössner, Nathalie Robaa, Dina Einsle, Oliver Sippl, Wolfgang Ovádi, Judit Jung, Manfred Chembiochem Full Papers We have discovered the sirtuin‐rearranging ligands (SirReals) as a novel class of highly potent and selective inhibitors of the NAD(+)‐dependent lysine deacetylase sirtuin 2 (Sirt2). In previous studies, conjugation of a SirReal with a ligand for the E3 ubiquitin ligase cereblon to form a so‐called proteolysis‐targeting chimera (PROTAC) enabled small‐molecule‐induced degradation of Sirt2. Herein, we report the structure‐based development of a chloroalkylated SirReal that induces the degradation of Sirt2 mediated by Halo‐tagged E3 ubiquitin ligases. Using this orthogonal approach for Sirt2 degradation, we show that other E3 ligases than cereblon, such as the E3 ubiquitin ligase parkin, can also be harnessed for small‐molecule‐induced Sirt2 degradation, thereby emphasizing the great potential of parkin to be used as an E3 ligase for new PROTACs approaches. Thus, our study provides new insights into targeted protein degradation in general and Sirt2 degradation in particular. John Wiley and Sons Inc. 2020-08-27 2020-12-01 /pmc/articles/PMC7754454/ /pubmed/32672888 http://dx.doi.org/10.1002/cbic.202000351 Text en © 2020 The Authors. Published by Wiley-VCH GmbH This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Full Papers
Schiedel, Matthias
Lehotzky, Attila
Szunyogh, Sandor
Oláh, Judit
Hammelmann, Sören
Wössner, Nathalie
Robaa, Dina
Einsle, Oliver
Sippl, Wolfgang
Ovádi, Judit
Jung, Manfred
HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
title HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
title_full HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
title_fullStr HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
title_full_unstemmed HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
title_short HaloTag‐Targeted Sirtuin‐Rearranging Ligand (SirReal) for the Development of Proteolysis‐Targeting Chimeras (PROTACs) against the Lysine Deacetylase Sirtuin 2 (Sirt2)
title_sort halotag‐targeted sirtuin‐rearranging ligand (sirreal) for the development of proteolysis‐targeting chimeras (protacs) against the lysine deacetylase sirtuin 2 (sirt2)
topic Full Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754454/
https://www.ncbi.nlm.nih.gov/pubmed/32672888
http://dx.doi.org/10.1002/cbic.202000351
work_keys_str_mv AT schiedelmatthias halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT lehotzkyattila halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT szunyoghsandor halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT olahjudit halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT hammelmannsoren halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT wossnernathalie halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT robaadina halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT einsleoliver halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT sipplwolfgang halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT ovadijudit halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2
AT jungmanfred halotagtargetedsirtuinrearrangingligandsirrealforthedevelopmentofproteolysistargetingchimerasprotacsagainstthelysinedeacetylasesirtuin2sirt2